Well , I hope this will give us an approval , but not follow up with treatment with leronlimab on outpatient up to 4 doses if needed , is taking unnecessary risk with patients life and our study.. 3 and 4 dose should be given every 1 week if needed for patients discharge for egc after 2 weeks treatment imo
I know you are also a physician but I just have a different opinion here..